Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
11.00
-0.72 (-6.11%)
Nov 5, 2024, 1:19 PM EST - Market open

Neumora Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for NMRA stock have an average target of 23.4, with a low estimate of 15 and a high estimate of 30. The average target predicts an increase of 112.82% from the current stock price of 11.00.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $23.4 $23 $30
Change +36.43% +112.82% +109.19% +172.85%

Analyst Ratings

The average analyst rating for NMRA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 344422
Buy 344432
Hold 000001
Sell 000000
Strong Sell 000000
Total 688855

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Hold
Downgrades
$18$15
Hold Downgrades $18$15 +36.43% Nov 5, 2024
Needham
Needham
Strong Buy
Reiterates
$23
Strong Buy Reiterates $23 +109.19% Oct 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +172.85% Oct 1, 2024
Needham
Needham
Strong Buy
Reiterates
$23
Strong Buy Reiterates $23 +109.19% Sep 12, 2024
RBC Capital
RBC Capital
Buy
Reiterates
$29
Buy Reiterates $29 +163.76% Sep 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.52
from -3.63
EPS Next Year
-1.62
from -1.52
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-------39.11M
Revenue Growth
--------
EPS
--7.64-10.84-4.81-3.63-1.52-1.62-1.63
EPS Growth
--------
Forward PE
--------
No. Analysts -----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a 99.7M
Avg n/a n/a 39.1M
Low n/a n/a 9.8M

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20242025202620272028
High -1.45 -1.52 -1.08
Avg -1.52 -1.62 -1.63
Low -1.56 -1.71 -1.98

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.